These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

650 related items for PubMed ID: 17460402

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Treatment of refractory pemphigus vulgaris with rituximab (anti-CD20 monoclonal antibody).
    Dupuy A, Viguier M, Bédane C, Cordoliani F, Blaise S, Aucouturier F, Bonnetblanc JM, Morel P, Dubertret L, Bachelez H.
    Arch Dermatol; 2004 Jan; 140(1):91-6. PubMed ID: 14732665
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Rituximab in the adjuvant treatment of pemphigus vulgaris: a prospective open-label pilot study in five patients.
    Goh MS, McCormack C, Dinh HV, Welsh B, Foley P, Prince HM.
    Br J Dermatol; 2007 May; 156(5):990-6. PubMed ID: 17355229
    [Abstract] [Full Text] [Related]

  • 6. Rituximab in refractory pemphigus vulgaris.
    Sorce M, Aricò M, Bongiorno MR.
    Dermatol Ther; 2008 Jul; 21 Suppl 1():S6-9. PubMed ID: 18727815
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Treatment of pemphigus vulgaris with rituximab and intravenous immune globulin.
    Ahmed AR, Spigelman Z, Cavacini LA, Posner MR.
    N Engl J Med; 2006 Oct 26; 355(17):1772-9. PubMed ID: 17065638
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Immunogenicity of rituximab in patients with severe pemphigus.
    Schmidt E, Hennig K, Mengede C, Zillikens D, Kromminga A.
    Clin Immunol; 2009 Sep 26; 132(3):334-41. PubMed ID: 19502112
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Rituximab: a monoclonal antibody to CD20 used in the treatment of pemphigus vulgaris.
    El Tal AK, Posner MR, Spigelman Z, Ahmed AR.
    J Am Acad Dermatol; 2006 Sep 26; 55(3):449-59. PubMed ID: 16908351
    [Abstract] [Full Text] [Related]

  • 15. Treatment of severe pemphigus with protein A immunoadsorption, rituximab and intravenous immunoglobulins.
    Shimanovich I, Nitschke M, Rose C, Grabbe J, Zillikens D.
    Br J Dermatol; 2008 Feb 26; 158(2):382-8. PubMed ID: 18070210
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Rituximab treatment of severe pemphigus: long-term results including immunologic follow-up.
    Reguiai Z, Tabary T, Maizières M, Bernard P.
    J Am Acad Dermatol; 2012 Oct 26; 67(4):623-9. PubMed ID: 22261417
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 33.